April 11, 2012
The Liddy Shriver Sarcoma Initiative has awarded a $250,000 grant to fund a new collaborative research study on myxoid liposarcoma. The grant brings together researchers from Canada, the Netherlands and the United States in a two-year study of this rare cancer.
Myxoid liposarcomas account for about 10% of all soft tissue sarcomas, which are rare cancers of the connective tissues. They typically affect adults between the ages of 30 and 50 years old and are prone to metastasize (spread throughout the body). There are currently no effective systemic therapies for the disease, which can be highly lethal.